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Protein tyrosine phosphatases and glucocorticoids are known to
regulate allergic and antiallergic action in activated mast cells.
Here we provide RNA sequencing and quantitative real-time PCR
data from bone marrow derived mast cells, for wild-type and
PEST-domain-enriched tyrosine phosphatase (PEP) null mice,
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treatment, and additionally treated with the glucocorticoid dex-
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duplicate with a total of 16 samples (GSE108972).
& 2018 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
st cells; COX-2, Cyclooxygenase 2; CSF2, Colony stimulating factor 2; DAVID,
ted Discovery; DEX, Dexamethasone; DNP, Dinitrophenol; IgE,
ove's Modiﬁed Dulbecco's Medium; KEGG, Kyoto Encyclopedia of Genes and
, PEST-domain-enriched tyrosine phosphatase; PTGDS, Prostaglandin D2
al-time polymerase chain reaction; RNA-seq, RNA-sequencing; SBS,
ctor alpha
to).








ore speciﬁc subject area Allergy
ype of data Transcriptome, ﬁgures, tables
ow data was acquired High-throughput RNA sequencing using Illumina HiSeq. 1500, quanti-
tative real-time PCR (qRT-PCR) using SYBR Green dye in a StepOne-
Plus™ Real-Time PCR systemata format Processed
xperimental factors Wild-type versus mutant cells
xperimental features Comparison of mRNA from PEPþ /þ and PEP / mouse bone marrow
derived mast cells (BMMCs) following activation with the antigen
dinitrophenol and additional treatment with the glucocorticoid
Dexamethasone.ata source location Karlsruhe Institute of Technology, Institute of Toxicology and Genetics
Hermann-von-Helmholtz-Platz-1, 76344 Eggenstein-Leopoldshafen,
Germanyata accessibility http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc¼GSE108972DValue of the data
 This dataset is a transcriptomic analysis of bone marrow derived mast cells (BMMCs) from PEPþ/þ
and PEP/ mice activated by antigen and additionally treated with glucocorticoids.
 These data provide RNA-seq and qRT-PCR gene expression results to show the role of PEP in
antigen-mediated mast cell activation and the inhibition of mast cell activation by glucocorticoids.
 These data will serve as a reference point for antigen-mediated activation of mast cells and the
antiallergic action of glucocorticoids.1. Data
The data show gene expression proﬁles of 16 RNA-sequencing (RNA-seq) samples, representing
two replicates each from BMMCs isolated from wild-type (PEPþ/þ ) and mutant (PEP/) mice:
 sensitized with Immunoglobulin E (IgE) (500 ng/ml) for 3 h
 sensitized with IgE (500 ng/ml) for 3 h and activated with the antigen dinitrophenol (DNP) (as
dinitrophenyl -bovine serum albumin, 200 ng/ml) for 1 h
 treated with dexamethasone (DEX) (107 M) for 8 h and IgE (500 ng/ml) for 3 h
 treated with DEX (107 M) for 8 h, IgE (500 ng/ml) for 3 h and DNP (200 ng/ml) for 1 h.
The data are deposited under the Gene Expression Omnibus (GEO) number GEO: GSE 108972 at
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc¼GSE108972.2. Experimental design, materials and methods
2.1. Preparation of the biological material
BMMCs from PEPþ/þ and PEP/ mice were isolated by culturing bone marrow cells from the
femur and tibia of male C57BL/6 mice aged 8–10 weeks in mast cell medium (IMDM supplemented
with 10% foetal calf serum, 2 mM L-glutamine, 1mM pyruvate, 100 ng stem cell factor/kit ligand,
5 ng/ml IL3, 50 mM β-mercaptoethanol, 1% penicillin/streptomycin 10,000 U/ml) in T-75 ﬂask at 37 °C,
Table 1
Outline of the different treatments administered prior to the transcriptomics study.
Sample name Genotype Treatment
PEPþ/þ IgE PEST-domain-enriched tyrosine
phosphatase WT
Immunoglobulin E
PEPþ/þ IgE DNP PEST-domain-enriched tyrosine
phosphatase WT
Immunoglobulin E þ dinitrophenol
PEPþ/þ IgE DEX PEST-domain-enriched tyrosine
phosphatase WT
Immunoglobulin E þ dexamethsone
PEPþ/þ IgE DNP DEX PEST-domain-enriched tyrosine
phosphatase WT
Immunoglobulin E þ dinitrophenol þ dexamethsone
PEP / IgE PEST-domain-enriched tyrosine
phosphatase mutant
Immunoglobulin E
PEP / IgE DNP PEST-domain-enriched tyrosine
phosphatase mutant
Immunoglobulin E þ dinitrophenol
PEP / IgE DEX PEST-domain-enriched tyrosine
phosphatase mutant
Immunoglobulin E þ dexamethsone
PEP / IgE DNP DEX PEST-domain-enriched tyrosine
phosphatase mutant
Immunoglobulin E þ dinitrophenol þ dexamethsone
Fig. 1. Principal Component Analysis (PCA) plot of normalized expression for the samples.
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G.K. Ainooson et al. / Data in Brief 20 (2018) 1177–118311805% CO2 and 95% humidity in an incubator. The culture medium was changed every three days by
centrifuging the suspended cells at 1300 rpm for 7min and re-suspending the resulting pellet in fresh
medium as previously described [1]. The BMMCs were used after 4 weeks in culture as described in
Table 1.
2.2. Preparation of libraries, sequencing and data analysis
For the RNAseq experiment, total RNA was extracted from 3106 PEPþ/þ and PEP/ BMMCs
using innuPREP RNA Mini Kit (Analytik Jena AG, Jena, Germany). A total of 1 mg RNA was used to
prepare mRNA sequencing libraries for each sample using the TruSeq stranded mRNA kit v2Fig. 2. Heatmap illustration of gene expression in sensitized (IgE) and activated (IgE þ DNP) mast cells: Color-coded heatmap
of the normalized expression level of genes representing two replicates each for PEPþ/þ and PEP/ BMMCs. The color
gradient shows blue for low and red for high expression of genes.
G.K. Ainooson et al. / Data in Brief 20 (2018) 1177–1183 1181(Illumina), according to the vendor´s protocol. Next, 10 pM of multiplexed libraries were used to
generate clusters in 2 lanes of a high-throughput ﬂowcell. A HiSeq. 1500 was used to obtain paired-
end reads of 50 bases using the sequencing by synthesis (SBS v3 kit Illumina). The cluster detection
and the base calling were done with the software RTA (v1.13 Illumina) and demultiplexing with the
software CASAVA (v1.8.1 Illumina). The sequencing resulted in 576 million reads with a mean quality
Phred score of 35.2. The quality of the sequencing data was ﬁrst assessed with FASTX toolkit (v0.0.13
[http://hannonlab.cshl.edu/fastx_toolkit/]) and no pre-processing was needed. The alignment of the
sequencing reads was done with Tophat2 (v2.0.11) [2] against the mouse reference genome (GRCm38
v75). The raw count per gene was calculated using HTSeq (v0.5.3) [3]. The normalization of the
counts, the differential expression analysis were done using the R software packages including DESeq.
2 [4]. The reproducibility of the biological replicates for all the conditions examined was assessed byFig. 3. Heatmap illustration of gene expression pattern in activated (IgE þ DNP) and activated mast cells treated with dex-
amethasone (IgE þ DNP þ DEX). Color-coded heatmap of the normalized expression level of genes representing two replicates
for PEPþ/þ and PEP/ BMMC. The color gradient shows blue for low expression and red for high expression.
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were subjected to hierarchical clustering using hclust and gplot R packages. These were done for the
activation of the mast cells by antigen (DNP) alone (Fig. 2) or together with DEX treatment (Fig. 3).
2.3. Validation of distinct target genes
KEGG pathway analysis of genes signiﬁcantly deregulated upon PEP gene deletion was carried out
using DAVID [5]. Genes associated with antigen receptor (FcεRI signaling pathway) (IL 13, TNFα, and
CSF2) and arachidonic acid metabolism pathway (COX-2, PTGDS) were some of the key genes identiﬁedFig. 4. qRT-PCR validation of the expression of some genes differentially misregulated in the RNA-seq studies. A. Gene
expression pattern of cytokine/chemokine genes identiﬁed to be differentially misregulated in response to antigen (IgE þ DNP)
compared to IgE treatment. The results are presented as the mean 7 standard error of mean. * p o 0.05, *** p o 0.001 for
unpaired two-tailed t test (n ¼ 3). B. Dexamethasone-induced regulation of expression of lipid mediator genes, COX-2
(cyclooxygenase-2) and PTGDS (prostaglandin D2 synthase - lipocalin-type) identiﬁed as differentially misregulated in PEP/
 BMMCs compared to the PEPþ/þ BMMCs. The results are presented as the mean 7 standard error of mean. * p o 0.05, ** p
o 0.01 for unpaired two tail t test (n ¼ 5).
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these results was carried out using qRT-PCR analyses. 1 mg of RNA was reversed transcribed to com-
plementary DNA (cDNA) and used for real-time PCR (StepOnePlus Life Technologies, Carlsbad, California)
with gene-speciﬁc primers for the following genes: IL 13 (Forward 50-TGGCTCTTGCTTGCCTTGGT-30,
Reverse 50-TTTTGGTATCGGGGAGGCTGG-30), TNFα (Forward 50-GATCGGTCCCCAAAGAAGGGATG-30,
Reverse 50-TGATCTGAGTGTGAGGGTCTCG-30), CSF2 (Forward 50-TCGTCTCTAACGAGTTCTCCTT-30, Reverse
50-CGTAGACCCTGCTCGAATATCT-30), COX-2 (Forward 50-TGAGCAACTATTCCAAACCAGC-30, Reverse
50-GCACGTAGTCTTCGATCACTATC-30), PTGDS (Forward 50-GCTCCTTCTGCCCAGTTTTCCT-30, Reverse
50-GGAGGACCAAACCCATCCAC-30) and in parallel with a reference gene Ribosomal protein large P0
subunit (Rplp0) (Forward 50-GGACCCGAGAAGACCTCCTT-30, Reverse 50-GCACATCACTCAGAATTTCA-30).
The gene-speciﬁc primers were designed using the publicly available web-based tool ‘Primer-BLAST’
NCBI-NIH. The relative mRNA transcript abundance for the test genes in each sample was calculated using
the 2(ΔΔCT) method [6] for the role of PEP in antigen-mediated mast cell activation (Fig. 4A) and the
effect of DEX on antigen-mediated mast cell activation (Fig. 4B).Acknowledgements
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